Clinical trial
Pilot Study, Without Direct Individual Benefice, of Biological Effect of Tarceva (OSI-774) at Posology of 150 mg by Day for Patients Stricken by ENT Epidermoid Carcinoma Waiting for First Surgical Picking up.
NCT00144976 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study, Without Direct Individual Benefice, of Biological Effect of Tarceva (OSI-774) at Posology of 150 mg by Day for Patients Stricken by ENT Epidermoid Carcinoma Waiting for First Surgical Picking up.
- Lead sponsor
- Institut Claudius Regaud
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2003
- Completion date
- December 31, 2006
- Enrollment
- 43 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.